What are the benefits of fibrinolytic therapy in the treatment of myocardial infarction (MI)?

Updated: Aug 04, 2021
  • Author: Wanda L Rivera-Bou, MD, FAAEM, FACEP; Chief Editor: Erik D Schraga, MD  more...
  • Print


The benefits of fibrinolytic therapy are well established during the initial 12 hours after symptom onset. Guidelines mention that administration of a fibrinolytic agent should be considered in symptomatic patients presenting more than 12-24 hours after symptom onset with STEMI affecting a large area of myocardium or hemodynamic instability if PCI is not available.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!